Sleuth for Biotech Leadership

Punch above your weight on every strategic call

Sleuth gives biotech leadership a single workspace for competitive intelligence, landscape analysis, and strategic positioning across every area your pipeline touches. The same analytical depth pharma relies on, built for your team size and your timeline.

The Challenge

Every program carries the whole company

You are the strategy team

Every strategic question lands on your desk. Competitive positioning, indication selection, partnership landscape, investor narrative. There's no one to hand it to and no time to do it twice.

One readout can reshape your narrative

Your fundraise timeline, your board thesis, your next partnering conversation. A single competitor data drop can put all of it into an existential crisis overnight.

Pharma-grade decisions on a biotech budget

The analytical bar for an indication bet or a partnership negotiation doesn't shrink because your team did. You need the same depth pharma commissions from teams of consultants.

How Sleuth helps

Built for how biotech leaders actually work

Strategic depth without the headcount

Sleuth covers competitive positioning, landscape analysis, and indication-level intelligence across every area your pipeline touches. You get the analytical capacity of a dedicated strategy team without building one.

An updated view before the next call

Sleuth monitors competitive landscapes, clinical readouts, and deal activity continuously. When a competitor drops data or a new filing surfaces, your view reflects it. You respond from a current picture, not a stale one.

Pharma depth, biotech speed

Sleuth delivers analysis that pharma commissions from large consulting firms, tailored to your pipeline, your indications, and your strategic questions. In days, at a fraction of the cost.

What teams are saying

“All the strategy that used to be proprietary to pharma and top-tier VCs — the ‘game within the game’ that actually drives indication decisions — Sleuth made that accessible to a nine-person biotech. I think it's the most disruptive, amazing thing for small organizations like us. A massive, massive unlock.”

Danny Wells
CEO
Epana Bio
Sleuth Intelligence

Strategic depth from teams like yours

Walk into your next board meeting ready